Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hamann

Showing results (41-50 of 118) with videos related to

Pageof 12
Sort By:
Schmerz (Berlin, Germany)|October 28, 1996
[Substance P, somatostatin and monoaminergic transmitters in the cerebrospinal fluid of patients with chronic idiopathic trigeminal neuralgia]M Strittmatter, M Grauer, E Isenberg, et al.
Headache|April 1, 1997
Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgiaM Strittmatter, M Grauer, E Isenberg, et al.
Perfusion|April 24, 2003
Neurological and neuropsychological examination and outcome after use of an intra-aortic filter device during cardiac surgeryS Eifert, H Reichenspurner, T Pfefferkorn, et al.
Journal of Medicinal Chemistry|February 2, 1999
Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071)L G Hamann, N S Mani, R L Davis, et al.
Bioorganic & Medicinal Chemistry Letters|April 1, 2000
Effects of isosteric pyridone replacements in androgen receptor antagonists based on 1,2-dihydro- and 1,2,3,4-tetrahydro-2,2-dimethyl-6-trifluoromethyl-8-pyridono[5,6-g]quin olinesJ W Kong, L G Hamann, D A Ruppar, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2005
Seco-prolinenitrile inhibitors of dipeptidyl peptidase IV define minimal pharmacophore requirements at P1David R Magnin, Prakash C Taunk, James G Robertson, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
Synthesis and SAR of azolopyrimidines as potent and selective dipeptidyl peptidase-4 (DPP4) inhibitors for type 2 diabetesRobert P Brigance, Wei Meng, Aberra Fura, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2013
Substituted piperidinyl glycinyl 2-cyano-4,5-methano pyrrolidines as potent and stable dipeptidyl peptidase IV inhibitorsGuohua Zhao, Chet Kwon, Aiying Wang, et al.
Organic Letters|October 25, 2012
One-pot C-N/C-C cross-coupling of methyliminodiacetic acid boronyl arenes enabled by protective enolizationJonathan E Grob, Michael A Dechantsreiter, Ritesh B Tichkule, et al.
Archives of Biochemistry and Biophysics|December 21, 2005
Mechanism of Gly-Pro-pNA cleavage catalyzed by dipeptidyl peptidase-IV and its inhibition by saxagliptin (BMS-477118)Young B Kim, Lisa M Kopcho, Mark S Kirby, et al.
Pageof 12

Showing results (41-50 of 118) with videos related to

Sort By:
Pageof 12
Schmerz (Berlin, Germany)|October 28, 1996
[Substance P, somatostatin and monoaminergic transmitters in the cerebrospinal fluid of patients with chronic idiopathic trigeminal neuralgia]M Strittmatter, M Grauer, E Isenberg, et al.
Headache|April 1, 1997
Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgiaM Strittmatter, M Grauer, E Isenberg, et al.
Perfusion|April 24, 2003
Neurological and neuropsychological examination and outcome after use of an intra-aortic filter device during cardiac surgeryS Eifert, H Reichenspurner, T Pfefferkorn, et al.
Journal of Medicinal Chemistry|February 2, 1999
Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071)L G Hamann, N S Mani, R L Davis, et al.
Bioorganic & Medicinal Chemistry Letters|April 1, 2000
Effects of isosteric pyridone replacements in androgen receptor antagonists based on 1,2-dihydro- and 1,2,3,4-tetrahydro-2,2-dimethyl-6-trifluoromethyl-8-pyridono[5,6-g]quin olinesJ W Kong, L G Hamann, D A Ruppar, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2005
Seco-prolinenitrile inhibitors of dipeptidyl peptidase IV define minimal pharmacophore requirements at P1David R Magnin, Prakash C Taunk, James G Robertson, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
Synthesis and SAR of azolopyrimidines as potent and selective dipeptidyl peptidase-4 (DPP4) inhibitors for type 2 diabetesRobert P Brigance, Wei Meng, Aberra Fura, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2013
Substituted piperidinyl glycinyl 2-cyano-4,5-methano pyrrolidines as potent and stable dipeptidyl peptidase IV inhibitorsGuohua Zhao, Chet Kwon, Aiying Wang, et al.
Organic Letters|October 25, 2012
One-pot C-N/C-C cross-coupling of methyliminodiacetic acid boronyl arenes enabled by protective enolizationJonathan E Grob, Michael A Dechantsreiter, Ritesh B Tichkule, et al.
Archives of Biochemistry and Biophysics|December 21, 2005
Mechanism of Gly-Pro-pNA cleavage catalyzed by dipeptidyl peptidase-IV and its inhibition by saxagliptin (BMS-477118)Young B Kim, Lisa M Kopcho, Mark S Kirby, et al.
Pageof 12